ECT2 and endometrial cancer: By retrieving and obtaining transcriptome sequencing data from 554 endometrial cancer samples in the TCGA database (https://cancergenome.nih.gov/), significant differences were found in the expression level of ECT2 between endometrial cancer and normal endometrium (Figure 7A), Moreover, survival analysis revealed that the expression level of ECT2 was related to the prognosis of patients.